How To Use CPT Code 0631T

CPT 0631T describes the use of transcutaneous visible light hyperspectral imaging to measure oxyhemoglobin, deoxyhemoglobin, and tissue oxygenation in a specific extremity. This article will cover the official description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, and examples of CPT code 0631T.

1. What is CPT Code 0631T?

CPT 0631T can be used to describe the measurement of oxyhemoglobin, deoxyhemoglobin, and tissue oxygenation using transcutaneous visible light hyperspectral imaging. This procedure involves the use of a specialized device that differentiates light absorption between oxygenated and deoxygenated hemoglobin, providing valuable information about tissue perfusion and potential ischemic areas. The provider interprets the data obtained from the imaging and completes a report based on their findings.

2. Official Description

The official description of CPT code 0631T is: ‘Transcutaneous visible light hyperspectral imaging measurement of oxyhemoglobin, deoxyhemoglobin, and tissue oxygenation, with interpretation and report, per extremity.’

3. Procedure

1. The provider uses a hyperspectral imaging device that captures and quantifies light absorption in hemoglobin molecules using visible light and a spectrometer.
2. The device generates color-coded images that represent concentrations of oxyhemoglobin, deoxyhemoglobin, and oxygen saturation in the blood.
3. The provider analyzes the images and identifies areas of potential ischemic tissue, which may indicate restricted blood supply.
4. The provider completes a report based on their interpretation of the data, documenting their findings and any relevant clinical observations.

4. Qualifying circumstances

CPT 0631T is typically used for patients who require evaluation of tissue perfusion and potential ischemic areas. This may include individuals with non-healing wounds, such as diabetic foot ulcers, or other conditions where assessing tissue oxygenation is crucial. The procedure is performed on a per extremity basis, meaning it applies to a specific limb or body part.

5. When to use CPT code 0631T

CPT code 0631T should be used when a provider performs transcutaneous visible light hyperspectral imaging to measure oxyhemoglobin, deoxyhemoglobin, and tissue oxygenation in a specific extremity. It is important to note that this code should not be reported in conjunction with codes 94760, 94761, 94762, or 0061U, as they represent different procedures or services.

6. Documentation requirements

To support a claim for CPT code 0631T, the provider must document the following information:

• The specific extremity evaluated using transcutaneous visible light hyperspectral imaging
• The date of the procedure
• The start and end time of the imaging session
• The interpretation of the data, including any findings related to tissue oxygenation and potential ischemic areas
• Any additional relevant clinical observations or recommendations
• The provider’s signature

7. Billing guidelines

When billing for CPT code 0631T, ensure that the procedure was performed using transcutaneous visible light hyperspectral imaging and that the interpretation and report were completed. It is important to review the guidelines and notes associated with this code to ensure accurate reporting. Additionally, do not report CPT code 0631T in conjunction with codes 94760, 94761, 94762, or 0061U.

8. Historical information

CPT code 0631T was added to the Current Procedural Terminology system on January 1, 2021. As of now, there have been no updates or changes to this code.

9. Examples

1. A provider uses transcutaneous visible light hyperspectral imaging to assess tissue oxygenation and potential ischemic areas in a patient’s lower extremity with a non-healing wound.
2. During a procedure, a provider utilizes transcutaneous visible light hyperspectral imaging to evaluate tissue perfusion in a specific upper extremity of a patient with suspected vascular compromise.
3. A provider performs transcutaneous visible light hyperspectral imaging to assess tissue oxygenation and potential ischemic areas in a patient’s foot affected by a chronic condition.
4. Using transcutaneous visible light hyperspectral imaging, a provider evaluates tissue perfusion and potential ischemic areas in a patient’s hand following a traumatic injury.
5. A provider utilizes transcutaneous visible light hyperspectral imaging to assess tissue oxygenation and potential ischemic areas in a patient’s leg affected by a chronic vascular condition.
6. During a procedure, a provider performs transcutaneous visible light hyperspectral imaging to evaluate tissue perfusion in a specific extremity of a patient with a non-healing surgical wound.
7. A provider uses transcutaneous visible light hyperspectral imaging to assess tissue oxygenation and potential ischemic areas in a patient’s arm affected by a chronic condition.
8. Using transcutaneous visible light hyperspectral imaging, a provider evaluates tissue perfusion and potential ischemic areas in a patient’s foot following a recent vascular procedure.
9. A provider utilizes transcutaneous visible light hyperspectral imaging to assess tissue oxygenation and potential ischemic areas in a patient’s hand affected by a chronic vascular condition.
10. During a procedure, a provider performs transcutaneous visible light hyperspectral imaging to evaluate tissue perfusion in a specific extremity of a patient with a non-healing diabetic ulcer.